VERRICA PHARMACEUTICALS INC
VRCANASDAQ🏆 #3437 by market capEarnings Nov 13US Equity
$525.50▲ $45.93 (+8.74%)
Simulated price1h—
24h▲ 8.7%
7d—
14d—
30d—
1y—
🏦Market Cap
$90M
Small Cap
📈Revenue Growth (YoY)
+417.6%
High Growth
📊Gross Margin
89.5%
High
💵FCF Margin
—
⚖️P/S Ratio
2.3x
Cheap
Otter Score
69
Fair
📊
Analyst Ratings
Price
$525.50
Total
10
Raised
1
Lowered
2
Avg PT
$13.25
H / L
$17 / $10
| Institution | Action | Rating | Date |
|---|---|---|---|
Brookline Capital | Upgraded | Hold → Buy | 2025-12-18 |
Needham | Reiterated | Hold | 2025-05-14 |
HC Wainwright & Co. | Reiterated | Neutral | 2025-04-08 |
RBC Capital | Downgraded | Outperform → Sector Perform | 2024-11-05 |
TD Cowen | Reiterated | Buy | 2024-10-21 |
Jefferies | Reiterated | Buy | 2023-12-15 |
B of A Securities | Downgraded | Buy → Neutral | 2020-07-15 |
Northland Capital Markets | Reiterated | Outperform | 2020-06-24 |
H.C. Wainwright | Reiterated | Buy | 2019-02-21 |
Cowen & Co. | Reiterated | Outperform | 2018-07-10 |
One row per institution, most recent rating